Roberta L. Buell is a Principal at onPoint Oncology Inc., specializing in oncology reimbursement. With over 23 years of experience in billing, coding, and drug therapy reimbursement, she's a nationally recognized expert and frequent speaker on regulatory and reimbursement issues. Bobbi has led more than 600 seminars since 1991 and currently serves as content director for focalPoint® and assistPoint®. Learn more about Bobbi here .
PBM reform stalls, Haemanthus faces Theranos scrutiny, and UnitedHealth slashes broker pay. Get the latest on drug pricing, RPM policy, and Medicare changes.
The 2025 budget bill proposes major Medicaid cuts, ACA rollbacks, new work requirements, and a limited Medicare doc fix. Big changes ahead if it passes.
Trump’s new Executive Order revives Most Favored Nation drug pricing, aiming to lower U.S. costs by matching lowest global prices. Legal challenges expected.
See Q3 2025 HCPCS drug code changes effective July 1: new, revised, and discontinued codes for epinephrine, naloxone, CAR-T, biosimilars, and more on BuyandBill.com.
No articles match your search.
The Comparative Report puts ASP, the Medicare payment limit, WAC and AWP for up to 15 drugs on one timeline. Ten-plus years of monthly history, per HCPCS unit.
Included with BuyandBill Pro for $37/month billed annually.
Trastuzumab class, seven products
Actual published ASP, Jan 2015 to Aug 2026.
